FENIVIR

This brand name is authorized in Austria, Cyprus, Estonia, Spain, Lithuania, South Africa

Active ingredients

The drug FENIVIR contains one active pharmaceutical ingredient (API):

1 Penciclovir UNII 359HUE8FJC - PENCICLOVIR

Penciclovir has demonstrated in vivo and in vitro activity against herpes simplex viruses (types 1 and 2) and varicella zoster virus. Penciclovir triphosphate persists in infected cells for more than 12 hours where it inhibits replication of viral DNA and has a half-life of 9, 10 and 20 hours in cells infected with varicella zoster virus, herpes simplex virus type 1 and herpes simplex virus type 2 respectively. Read about Penciclovir

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D06BB06	Penciclovir	D Dermatologicals → D06 Antibiotics and chemotherapeutics for dermatological use → D06B Chemotherapeutics for topical use → D06BB Antivirals
Discover more medicines within D06BB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1038507
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 61462
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1017870, 1037493
Country: ZA	Health Products Regulatory Authority	Identifier(s): 31/20.2.8/0077